Evolent Health, Inc.

Equities

EVH

US30050B1017

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX 16:39:02 13/09/2024 BST 5-day change 1st Jan Change
30.12 USD -0.08% Intraday chart for Evolent Health, Inc. -1.84% -9.32%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Evolent Health Insider Sold Shares Worth $1,070,798, According to a Recent SEC Filing MT
Evolent Health Insider Sold Shares Worth $1,340,790, According to a Recent SEC Filing MT
Evolent Health Insider Sold Shares Worth $5,637,120, According to a Recent SEC Filing MT
Evolent Health's Standardized, Formulaic Pricing Approaches to Help Manage Volatility Going Forward, RBC Says MT
Sector Update: Health Care Stocks Rise Premarket Friday MT
Evolent Health Better Suited for Leveraged Buyout Than Strategic Deal With Health Insurer, Truist Says MT
Evolent Health Reportedly in Sale Talks After Receiving Takeover Interest CI
Sector Update: Health Care Stocks Mixed Late Afternoon MT
Exclusive-Evolent Health in sale talks after receiving takeover interest, sources say RE
Evolent Health in Discussions Over Potential Sale MT
Sector Update: Health Care Stocks Softer in Afternoon Trading MT
Evolent Health in Discussions Over Potential Sale MT
Evolent Health in Discussions Over Potential Sale, Reuters Says MT
Evolent Health in Talks to Sell After Receiving Interest, Reuters Reports MT
Evolent Health's Rate Increases Improve Visibility, Truist Says MT
Sector Update: Health Care Stocks Edge Higher Pre-Bell Friday MT
Sector Update: Health Care MT
Evolent Health Q2 Adjusted Earnings, Revenue Climb; Lifts Lower End of FY Revenue Guidance MT
Truist Securities Upgrades Evolent Health to Buy From Hold, Adjusts Price Target to $33 From $28 MT
Transcript : Evolent Health, Inc., Q2 2024 Earnings Call, Aug 08, 2024
Earnings Flash (EVH) EVOLENT HEALTH Posts Q2 EPS $0.30 MT
Earnings Flash (EVH) EVOLENT HEALTH Posts Q2 Revenue $647.1M, vs. Street Est of $636.4M MT
Evolent Health, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
Evolent Health, Inc. Provides Earnings Guidance for the Third Quarter Ending September 30, 2024 and for the Full Year Ending December 31, 2024 CI
Evolent Health, Inc. completed the acquisition of Certain assets of Machinify Inc. CI
Chart Evolent Health, Inc.
More charts
Logo Evolent Health, Inc.
Evolent Health, Inc. is a health care company connecting care for people with complex conditions like cancer, cardiovascular disease, and musculoskeletal diagnoses. The Company offers three primary solutions: specialty care management services, total cost of care management and administrative services. It provides comprehensive quality management for oncology and cardiology patients from diagnosis through advance care planning services as well as identifying quality, lowest cost of care for outpatient orthopedic surgeries. Its total cost of care management solution enables providers to manage populations they may be accountable for under value-based contracts with payers or accountable care organizations (ACO) contracts with Centers for Medicare and Medicaid Services (CMS). Its administrative services solution includes integrated value-based care platform designed to help customers manage and administer patient health in a cost-effective manner.
Employees
4,700
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
30.15USD
Average target price
42.15USD
Spread / Average Target
+39.79%
Consensus
  1. Stock Market
  2. Equities
  3. EVH Stock
  4. News Evolent Health, Inc.
  5. Sector Update: Health Care Stocks Edge Higher Pre-Bell Friday
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW